Tag: Health Care

Displaying 521 - 540 of 811 results.

The consent order settled charges that Cephalon's proposed acquisition of Cima Labs, Inc. would allow Cephalon to continue its monopoly in the United States market for drugs that eliminate or reduce the spikes of severe pain that chronic cancer patients experience. The consent order...
  Under a consent agreement announced today, the Federal Trade Commission will allow Cephalon, Inc.’s $515 million acquisition of Cima Labs, Inc., provided that Cephalon grants Barr Laboratories, Inc. a fully paid-up, irrevocable license to manufacture and sell a generic formulation of Cephalon’s...
Commission authorization of staff amicus brief filing: The Commission has authorized the staff to file a joint amicus brief in Spano, et al. v. SAFECO Insurance Co. of America, et al., No 04-35313 (9th Cir.).
In a decision filed today, the Federal Trade Commission denied the motion of the South Carolina State Board of Dentistry to dismiss this action on the ground that its actions were protected by the state action doctrine. The Commission concluded that the Board’s “emergency regulation,” which...
The consent order settled antitrust concerns that Sanofi's proposed $64 billion acquisition of Aventis would create significant overlaps in several markets for pharmaceutical products while creating the world's third largest pharmaceutical company. Under terms of the consent order,...
Under the terms of a consent agreement announced today, the Federal Trade Commission would allow France’s Sanofi-Synthélabo’s (Sanofi) $64 billion acquisition of Aventis, provided the companies divest certain assets and royalty rights in the overlapping markets for factor Xa inhibitors used as...
Commission authorization of joint amicus brief filing: The Commission has authorized the filing of a joint amicus brief with the U.S. Department of Justice (DOJ) in Andrx Pharmaceuticals, Inc. v. Kroger Company, et al. (U.S. Court of Appeals for the Sixth Circuit). This case concerns a private...
Joint brief of the United States and the Federal Trade Commission, urging the Court to deny a writ of certiorari in this case, regarding private patent litigation and the legal standards applicable to “reverse payment” patent litigation settlements in the Hatch-Waxman context...
A Roswell, New Mexico physicians’ association, Southeastern New Mexico Physicians IPA, settled charges that it and two of its employees entered into collective agreements among physician members on fees and refused to deal with health plans that did not accept the collective agreed-...
  A Roswell, New Mexico-based physicians' association and two of its employees have agreed to settle Federal Trade Commission charges that they orchestrated agreements among Southeastern New Mexico Physicians IPA (SENM) members to fix prices and to refuse to deal with payors except on collectively...
Joint brief of the United States and the Federal Trade Commission urging reversal of district court order dismissing private antitrust action on grounds of the state action doctrine.
Commission authorization of the staff to file amicus brief: The Commission has authorized the filing of a joint amicus brief with the Department of Justice in McMahon v. Advanced Title Services Company of West Virginia, a case before the West Virginia Supreme Court of Appeals. The case concerns an...
Commission approval of final consent order: By a vote of 5-0, the Commission has approved a final consent order and authorized the staff to send letters to the commentors of record in the matter concerning California Pacific Medical Group, Inc, d/b/a Brown & Toland Medical Group. The FTC...
In response to requests from Rhode Island Attorney General Patrick C. Lynch and Deputy Senate Majority Leader Juan M. Pichardo, FTC staff have commented on seven state bills that contain so-called “freedom of choice” and “any willing provider” provisions for pharmaceutical sales. Although the...
Commission filing of complaint, stipulation, and judgment: The Commission has filed in Federal court its complaint, stipulation, and agreed-to judgment against RHI AG (RHI) to resolve charges that RHI violated various provisions of an FTC order issued in 2001. Under the terms of the settlement,...
The Commission argues that the district court erred by dismissing Teva's complaint against Pfizer in this Hatch-Waxman Act case. Teva sought a declaratory judgment that its generic version of sertraline hydrochloride would not infringe a patent held by Pfizer (or that the patent was...
The Federal Trade Commission today announced that it has closed its antitrust investigation into Caremark Rx, Inc.’s proposed acquisition of Advance PCS, and that it has notified the companies of this decision. The transaction involves two providers of prescription benefit management (PBM)...

Pages